1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
"Environmental Exposure Detection Technologies and/or Decontamination Treatments for Military Working Dogs (SBIR)" is currently closed and not accepting applications.
Environmental Exposure Detection Technologies and/or Decontamination Treatments for Military Working Dogs (SBIR) is sponsored by Department of Defense (DoD), Defense Health Agency (DHA). This DoD SBIR opportunity focuses on environmental exposure detection technologies, although specifically for military working dogs, it aligns with pollution detection principles.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Environmental Exposure Detection Technologies and/or Decontamination Treatments for Military Working Dogs - SBIR DHA26BZ01-NV003 — BW&CO Environmental Exposure Detection Technologies and/or Decontamination Treatments for Military Working Dogs - SBIR DHA26BZ01-NV003 Active specific topic DSIP This topic was temporarily posted by the Department of War SBIR Program on March 2nd 2026 and removed the following day.
We believe this topic is planned to be released once the SBIR program is reauthorized; however, this topic may ultimately be modified or withdrawn. Notify Me When This is Released Develop decontamination treatments for military working dogs that have been exposed to toxic industrial chemicals and materials through the performance of their duties.
This topic is in support of the DoD Working Dog Strategic Research Plan concerning mitigation, countermeasures and treatments for toxin/toxic exposures1. In modern military operations, military working dogs (MWDs) are at risk of exposure by many different types of hazardous materials.
These include toxic industrial chemicals (TICs) and materials (TIMs) such as hydrocarbons, polychlorinated biphenyls, glycols, hazardous metals, gases (hydrogen cyanide, hydrogen sulfide, freon, carbon monoxide, etc.), acids and alkali substances. Techniques for the decontamination of hazardous material exposures to the surface of the MWD are well defined2,3,4.
Although there are useful treatment options for external decontamination, there are few treatment options for toxic exposures that have been absorbed into the body of the MWD. The objective of this topic is to develop new treatments for MWDs against hazardous materials that have been absorbed into the body either through the skin or mucous membranes, by inhalation, or ingestion.
Current systemic treatments employed to care for MWDs include supportive antibiotic therapy for sulfur mustard, atropine injections for nerve agents, and Narcan for narcotics, but there are limited treatment options available for TIC/TIM exposures4,5,6.
Systemic treatments for the MWD should be able to be performed by veterinarians and their support personnel (trained animal care specialists (68T) in Role 1 and/or veterinary medical and surgical teams (VMST) in Role 2).
Potential MWD systemic treatments could include but are not limited to kits containing indicators or detectors of TIC/TIM exposure with easily identifiable injectable treatments for the identified contaminant (indicator/detector) and/or hemoperfusion systems and filters that can be used to remove contaminants from the blood (systemic). This research topic does not support the use of canines for testing purposes.
Any animal testing would require use of a suitable animal model that would approximate the response of a canine. If you can achieve the objective above better than any other company on the market, you have a very high-likelihood of success and should apply. Who is eligible to apply?
Any company that meets the following criteria: U.S.-owned and controlled. 500 or fewer employees (including affiliates) 1) End-to-end support including, strategy, writing of the full proposal, and administrative & compliance support. 2) Proposal strategy and review.
3) Administrative & compliance support. Request to talk with a member of our team by completing the form below: Biotech Defense & Dual Use Technology DHA https://www. bwcoconsulting.
com Low-Cost Modular Payload Vehicle for Agile Electronic Warfare Swarms with Ground Launch Capability - SBIR Topic DAF26BZ01-NV003 Development of Wearable Device for Detecting Biomarkers and Treating Viral and Bacterial Infections - SBIR DHA26BZ01-NV004
According to the current listing, eligibility includes: Small businesses. (Generally aligns with federal SBIR eligibility). Confirm the full requirements in the official notice before applying.
The published deadline was June 3, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Environmental Exposure Detection Technologies and/or Decontamination Treatments for Military Working Dogs (SBIR) is funded by Department of Defense (DoD), Defense Health Agency (DHA). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Defense Health Agency (DHA) SBIR and STTR Programs is sponsored by Department of Defense (DoD), Defense Health Agency (DHA). Defense Health Agency (DHA) SBIR and STTR Programs is a grant from the Department of Defense Defense Health Agency that funds small businesses developing high-risk, high-impact medical technologies to improve warfighter health and survival.
Small Business Innovation Research (SBIR) Program (DoD Broad Agency Announcements) is sponsored by Department of Defense (DoD), Defense Health Agency (DHA). The DoD SBIR program seeks proposals from small businesses for research and development that responds to specific topics in defense-related health and medical technologies. The DHA SBIR program focuses on biomedical and health-focused technologies that enhance medical readiness, clinical care delivery, force health protection, operational medicine, and military healthcare modernization, including digital health systems and AI-enabled triage. Phase I awards support early feasibility studies and preliminary field-care algorithms.
CDMRP's FY26 portfolio funds 34 programs, and October 2026 is dense with full-application deadlines: PRCRP October 5, PCRP October 7, MRP October 14. Every one of them is gated behind a pre-application that closed months earlier. Here is what that two-step structure actually costs applicants, and how to be inside the gate for FY27.
Read articleThe Department's FY26 SBIR/STTR Release 3 opened June 24 with roughly 37 topics across DARPA, the Navy, the Air Force, and the defense components, all closing July 22. The compressed four-week window is unforgiving, but the bigger mistake founders make is treating every component the same. Here is how to read the release, the eligibility rules that disqualify good companies, and why the component you target matters more than the topic you pick.
Read articleDoW's 2026 SBIR Broad Agency Announcement now operates on a monthly pre-release / quarterly close cadence. The 42 topics closing June 24 are the first test of whether the new rhythm produces the steady-state deal flow defense innovators have been asking for since 2022.
Read article